… study showed that erlotinib and gefitinib had similar effectiveness but gefitinib had a better
safety profile compared to erlotinib… for NSCLC patients compared to erlotinib. However, further …

… if the comparative effects of gefitinib versus erlotinib would vary with these important clinical
factors and to explore the source of substantial heterogeneity, if present. Sensitivity analyses …

… In conclusion, the present study suggested radiotherapy plus erlotinib should be a
preferable modality compared with CCRT, with similar survival outcomes but better treatment …

… In this study, we compared the effects of erlotinib and carnertinib using a wide cohort of
human prostate cancer cell lines. This represents one of the main merit of our report. The HRPC …

… (gefitinib, erlotinib, … , erlotinib, or afatinib is most appropriate as a first-line therapy is still a
controversial issue. The aim of this study was to compare the effectiveness of gefitinib, erlotinib, …

… Therefore, we aimed to study the interaction of OSI and the experimental drug KP2187 from
… Herein we report on an extensive comparative study of the EGFR inhibitors regarding their …

… II study was carried out in patients with advanced NSCLC who had progressed on or following
first-line chemotherapy. Erlotinib 150 mg daily (monotherapy) or erlotinib … , erlotinib was …

… erlotinib, and icotinib, are reported to be effective in patients with brain metastases. However,
direct comparative studies … to brain metastases more effectively than erlotinib or icotinib in a …

… We did not plan to analyse gefitinib or erlotinib as second-line therapy because erlotinib
gained approval as second-line therapy late and the follow-up period is not long enough. …

… gefitinib- and erlotinib-treated groups in this study were 76.9% … , which are consistent with
previous studies.5, 6, 7, 9 The … Until now, comparative studies on gefitinib and erlotinib have …